Disturbances of Cardiohaemodynamics, Heart Rhythm, Lipid, Purine Metabolism and Systemic Inflammation and Efficiency of Their Correction in Patients with Postinfarction Cardiosclerosis, Associated with Hyperuricemia
Journal Title: Lviv Clinical Bulletin - Year 2017, Vol 2, Issue 18
Abstract
Introduction. The role of serum uric acid (SUA) in the process of atherosclerosis and atherotrombosis is controversial. Epidemiological studies have recently shown that SUA may be a risk factor for cardiovascular diseases and a negative prognostic marker for mortality in subjects with pre-existing heart failure. Aim. To study out disturbances of cardiohaemodynamics, heart rhythm, lipid, purine metabolism and systemic inflammation and efficiency of their correction in patients with postinfarction cardiosclerosis, associated with hyperuricemia. Materials and methods. 147 patients, (59.2 ± 0.8) years old, with postinfarction cardiosclerosis were included in this study. They were divided into 2 groups depending on presence of hyperuricemia. The I group included 106 patients with high SUA (0.59 ± 0.06) mmol/l and II group – 41 patients with normal level of SUA (0.32 ± 0.05) mmol/l. Comparable evaluation of cardiohaemodynamics, heart rhythm disturbances, lipid and purine metabolism’s violation and systemic inflammation were performed. According to program of treatment patients with high SUA, were divided in 4 groups: I – 30 patients, whom standard treatment was prescribed, II – 25 patients, who received eprosartan 600 mg instead of ACE-inhibitor, III – 25 patients, whom fenofibrate 200 mg additionally was given, IV – 26 patients, who received combination of eprosartan and fenofibrate. Echo, Holter ECG monitoring, markers of systemic inflammation (C reactive protein (CRP), Interleukin 1 (IL1), tumor necrosis factor α (TNF α)), lipidiogram were assessed before treatment and after 6 months. Results. Elevated SUA level was associated with progression of postinfarction heart remodeling: increasing of left ventricle mass index (LVMI (220.9 ± 6.9) g/m2)) and violation of its geometry, particularly, concentric hypertrophy (56.6 %), eccentric hypertrophy (40.6 %) with diastolic dysfunction. SUA levels correlated significantly with mitral A wave velocity (r = 0.61, p < 0.01), E wave deceleration time (r = 0.26, p < 0.01), E/A ratio (r = 0.21, p < 0.05). Heterogenity of ventricular repolarization, decrease of time indexes of heart rate variability, as well as high grade premature ventricular complexes were observed in these patients. The correlation between elevated levels of CRP and SUA (r = 0.7, p < 0.01), TNF α (r = 0.8, p < 0.01), IL-1 (r = 0.7, p < 0.01) were found, confirming the direct role of SUA in inflammation. Complex treatment with eprosartan provided significant regress of left ventricle hypertrophy (LVMI was decreased to 14.3 g/m2 and increasing of ejection fraction from (46.2 ± 1,2) to (52.4 ± 1,1) %, normalization of circadian index, heart rate, complete recovery from ventricular tachycardia, reduced quantity of ventricular premature beats on 64.0 %, reduced duration of Q-T and its dispersion on 21.1 % and increased heart rate variability. Target levels of blood pressure were achieved in 85.7 % patients. Usage of fenofibrate provided reduction of total cholesterol by 21.1%, triglycerides – 44.2 %, low density lipoprotein – 30.1 %, SUA – 37.5 %, CRP – 71.2 %, TNF α – 69.0 %, IL-1 – 47.1 % and an increase of high density lipoprotein – 30.7 %. Conclusions. The combined therapy with eprosartan and fenofibrate is an adequate means for hypertension control, correction of dislipidemia, hyperuricemia and inflammation, prevention of heart remodeling in patients with postinfarction cardiosclerosis, associated with hyperuricemia. It was associated with improvement of heart rate variability indexes as well as with decrease of incidence of life-threatening arrhythmias.
Authors and Affiliations
S. Lypovetska
Keywords
Related Articles
- EP ID EP254530
- DOI 10.25040/lkv2017.023.025
- Views 151
- Downloads 0
Labyrinthopathies (Vestibulopathies) in Practice of a Doctor-therapist
Introduction. In 1861, Prosper Meniere for the first time proved that the cause of dizziness, nystagmus, and vertigo disorders may be the disease of the anterior part of labyrinth. Today, illness with such symptoms belon...
TORCH-Infection and Its Possible Role in Syntropic Liver Damage in Patients with Systemic Lupus Erythematosus (literature review and clinical case description)
Introduction. One of the topical issues of clinical medicine is the effective providing of help to patients with syntropic and polymorbid lesions, among which special attention is paid to patients with diffuse connective...
Використання ортодонтичної брекет-системи як спосіб міжщелепної фіксації за умов травматичних переломів нижньої щелепи: ретроспективний аналіз літератури; власний досвід
Міжщелепна фіксація – важлива й невідʼємна складова лікування хворих із травматичними пошкодженнями щелепно-лицевої ділянки (ЩЛД), яка забезпечує оптимальний контакт оклюзійних поверхонь і може використовуватись як у вар...
Efficacy of Itopride in Treatment of Gastroparesis Considering the State of Carbohydrate Metabolism in Patients with Type 2 Diabetes Mellitus
Introduction. Diabetes mellitus (DM) is considered to be one of the most serious problems in internal medicine due to multiple organ lesions and irreversible changes in the functioning of the organism. At present, despit...
Герпесвирусы у больных системной красной волчанкой (обзор литературы и описание клинических случаев)
Введение. Системная красная волчанка (СКВ) - аутоиммунное заболевание невыясненной этиологии. В последние годы исследователи уделяют значительное внимание выяснению роли герпесвирусов в возникновении, патогенезе, способн...